Three signals, one mechanism
Romi finished its Sephora Hong Kong rollout with zero external capital. KOMFYMED took the Watsons derma slot that has belonged to La Roche-Posay and Avène. Dr. Sheth's put the BIS in-vivo line ahead of the marketing claim in its SKU title. In each case the retailer or the regulator recognised durability that already existed rather than creating it.